HeartBeam (BEAT) Share-based Compensation (2020 - 2026)
HeartBeam's (BEAT) quarterly Share-based Compensation came in at $1.7 billion in Q2 2026, up 44.52% year-over-year from $1.2 billion in Q2 2025, and up 39.77% quarter-over-quarter from $1.2 billion in Q1 2026.
Analysis
HeartBeam (BEAT) Share-based Compensation (2020 - 2026) Analysis & Trends
HeartBeam (BEAT) has reported Share-based Compensation for 7 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 44.52% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $380.3 million, a 778.42% increase from a year earlier, with the FY2025 full-year figure at $9.1 million, up 23.47% from the prior year.
- Share-based Compensation was $1.7 billion for Q2 2026 at HeartBeam, up from $1.2 billion in the prior quarter.
- Over five years, Share-based Compensation peaked at $1.7 billion in Q2 2026 and troughed at -$3.7 billion in Q4 2025.
- A 5-year average of -$41.0 million and a median of $983000.0 in 2023 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 113614.9% in 2024, down 277749.62% in 2024.
- Over 5 years, Share-based Compensation stood at $346000.0 in 2022, then soared by 243.06% to $1.2 million in 2023, then sank by 277749.62% to -$3.3 billion in 2024, then declined by 12.71% to -$3.7 billion in 2025, then jumped by 145.79% to $1.7 billion in 2026.
- The last three Share-based Compensation figures came in at $1.7 billion (Q2 2026), $1.2 billion (Q1 2026), and -$3.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 27.46 Mn |
| 10 | HeartBeam | 24.23 Mn | 24.23 Mn | - | 1.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Bn |
| Mar 31, 2026 | 1.22 Bn |
| Dec 31, 2025 | -3.71 Bn |
| Sep 30, 2025 | 9.03 Mn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | 1.11 Bn |
| Dec 31, 2024 | -3.30 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 926,000.00 |
| Jun 30, 2023 | 702,000.00 |
| Mar 31, 2023 | 393,000.00 |
| Dec 31, 2022 | 346,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 264,000.00 |
| Mar 31, 2022 | 159,000.00 |
| Dec 31, 2021 | 107,000.00 |
| Sep 30, 2021 | 53,000.00 |